Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods of prenatal diagnosis using digital pcr

A digital and chromosomal technology, applied in laboratory containers, chemical instruments and methods, biochemical equipment and methods, etc.

Active Publication Date: 2022-02-08
博康有限公司
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The real-time PCR is a non-invasive method, but its disadvantages are that it is limited to perform multiple tests simultaneously, requires the use of a standard curve for accurate detection of fetal genetic abnormalities, and requires a certain amount or more of samples

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of prenatal diagnosis using digital pcr
  • Methods of prenatal diagnosis using digital pcr
  • Methods of prenatal diagnosis using digital pcr

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1: Selection of control genes and target genes, as well as design of primer pairs and probes

[0047]For genetic analysis of fetal genes, e.g., trisomy and the like, such as analysis of genetic abnormalities, chromosome 21 selected (due to trisomy causes Down's syndrome) as a target chromosome, chromosome selected chromosome 1 and 2 as a control chromosome . Then, in order to detect genes, four genes selected region on chromosome 21 as the target gene, to select a region of a gene on chromosome 1 and chromosome 2 gene region of a gene as a control. According to these genes, primers designed to amplify each gene and a fluorescently labeled probe can be confirmed the amplification reaction product. These primers and probes, respectively. (Daejeon, Korea) and Thermo Fisher Scientific (USA) synthesized from Bioneer Co., Ltd. Chromosome 21, chromosome 1 and chromosome 2 as the selected region figure 1 As shown in the primer and probe sequences and design as shown in Tab...

Embodiment 2

[0054] Example 2: Digital PCR for normal or Down syndrome

[0055] gDNA normal or Down's syndrome (T21 of) purchased from Coriell, to obtain normal or Down's syndrome (T21 of) digital values ​​of gDNA PCR results.

[0056] The gDNA was used as a template, PCR QX200 digital system (Bio-Rad, USA) digital PCR. In order to establish the appropriate concentration for the samples of the digital PCR, gDNA 1-5000 fold serially diluted samples in the experiment. Preparing a reaction solution containing 0.5-1.0μM 0.1-0.25μM primers and probes as 20μl of PCR master mix digital (master mix), adjusted to a concentration of 2-10ng of sample injection (see Table 3), and assigned to the respective PCR tube. The PCR tube containing the solution is installed in the droplet generator DG8 cartridge, and dispensing the sample into the sample wells 20μl and 70μl of oil droplet generator (gasket (Gasket)) assigned to the oil hole. Subsequently, the gasket is mounted in the cartridge, and the droplet ge...

Embodiment 3

[0063] Example 3: Number of amniotic fluid samples of pregnant women with normal or Down syndrome

[0064] Extracting the fetus from the amniotic fluid sample cfDNA normal harbor or Down's syndrome (T21) fetuses of pregnant women. CfDNA as a template using fetal samples, digital PCR.

[0065] First, circulating nucleic acids using a QIAamp kit (Qiagen Cat. No. 55114, Qiagen, Germany), gDNA extracted from the cells. GDNA extraction carried out according to the manufacturer's manual. Specifically, the cells were lysed with lysis buffer protein, and 100μl of Proteinase K was added to 50ml centrifuge tube, to remove the protein component, thereby improving the purity of a sample. Then, a solution containing proteinase K, 50ml centrifuge tubes ACL buffer containing 1.0μg of vector RNA, followed by vortexing and the cell lysate buffer ACL. The mixture was incubated at 60 ℃ 30 minutes and then 3.6 ml of buffer ACB (lysate buffer) was added to the centrifuge tube, followed by vortexing t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method for prenatal diagnosis using digital PCR, more particularly, relates to a method for providing information for diagnosing fetal chromosomal aneuploidy, comprising the steps of: (a) extracting DNA from blood of a pregnant woman; (b) ) fractionating DNA according to size to obtain DNA having 1,000 bp or less; (c) using the DNA obtained in step (b), a control gene located on a chromosome not related to chromosomal aneuploidy, a control gene located on a chromosome performing digital PCR on the ploidy-related target gene; (d) calculating the ratio of the quantitative digital PCR value of the target gene to the quantitative digital PCR value of the control gene; and (e) when the ratio calculated in step (d) is 0.70‑1.14 , to determine the number of chromosomes in the fetus is normal.

Description

[0001] Cross-reference related application [0002] This application claims October 29, 2015 and October 14, 2016, filed Korean Patent Application No. 10-2015-0151313 and 10-2016-0133529 filed, the entire contents of which are incorporated herein by reference. Technical field [0003] The present invention relates to a method for using digital PCR prenatal diagnosis. [0004] Inventory background [0005] Due to reasons such as increasing the age of marriage and women of childbearing age increased, the probability of occurrence of fetal genetic disease rises sharply in the last 10 years. If the disease is detected at an early stage of pregnancy including fetal genetic diseases, including, it is possible to take early measures to ensure medical safety, and to reduce maternal and fetal pain. Therefore, early diagnosis of fetal genetic abnormalities is very important. Fetus genetic abnormalities may occur includes a portion chromosomal translocations, deletions, duplications, insertio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6883C12Q1/686
CPCC12Q1/686C12Q1/6883C12Q2600/156C12Q2563/159C12Q2545/114C12N15/1013C12Q1/6827C12Q2525/204C12Q2531/113C12Q2537/16C12Q2545/113C12Q2537/165B01L3/50855C12Q1/6851C12Q2563/107C12Q1/6806C12Q2600/112C12Q2600/16C12Q2600/166
Inventor 黃丞镛吴文珠金升俊延钟泌金芝勋李承容安正陈朴俊秀崔孝贞
Owner 博康有限公司